The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
Official Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
Study ID: NCT00838201
Brief Summary: The purpose of this study is to describe the safety and tolerability of up to 5 years (ie, 3 years under the 20040138 Amgen study and 2 years on this study) denosumab administration as measured by adverse events, immunogenicity, and safety laboratory parameters in subjects who previously received denosumab for non-metastatic prostate cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Research Site, Huntsville, Alabama, United States
Research Site, Anaheim, California, United States
Research Site, Laguna Hills, California, United States
Research Site, Long Beach, California, United States
Research Site, San Bernardino, California, United States
Research Site, San Diego, California, United States
Research Site, San Diego, California, United States
Research Site, Santa Monica, California, United States
Research Site, Middlebury, Connecticut, United States
Research Site, New Britain, Connecticut, United States
Research Site, Trinity, Florida, United States
Research Site, Fort Wayne, Indiana, United States
Research Site, Greenbelt, Maryland, United States
Research Site, Sartell, Minnesota, United States
Research Site, Omaha, Nebraska, United States
Research Site, Albany, New York, United States
Research Site, Bay Shore, New York, United States
Research Site, Garden City, New York, United States
Research Site, Poughkeepsie, New York, United States
Research Site, Lancaster, Pennsylvania, United States
Research Site, East Providence, Rhode Island, United States
Research Site, Myrtle Beach, South Carolina, United States
Research Site, Dallas, Texas, United States
Research Site, Salem, Virginia, United States
Research Site, Burien, Washington, United States
Research Site, Seattle, Washington, United States
Research Site, Tacoma, Washington, United States
Research Site, Calgary, Alberta, Canada
Research Site, Kelowna, British Columbia, Canada
Research Site, Surrey, British Columbia, Canada
Research Site, Vancouver, British Columbia, Canada
Research Site, Victoria, British Columbia, Canada
Research Site, Victoria, British Columbia, Canada
Research Site, Barrie, Ontario, Canada
Research Site, Brantford, Ontario, Canada
Research Site, Burlington, Ontario, Canada
Research Site, Burlington, Ontario, Canada
Research Site, Guelph, Ontario, Canada
Research Site, Kingston, Ontario, Canada
Research Site, Kitchener, Ontario, Canada
Research Site, London, Ontario, Canada
Research Site, Markham, Ontario, Canada
Research Site, Newmarket, Ontario, Canada
Research Site, North Bay, Ontario, Canada
Research Site, North York, Ontario, Canada
Research Site, Oakville, Ontario, Canada
Research Site, Oshawa, Ontario, Canada
Research Site, Scarborough, Ontario, Canada
Research Site, Sudbury, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Greenfield Park, Quebec, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Seinajoki, , Finland
Research Site, Tampere, , Finland
Research Site, Balatonfured, , Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Gyor, , Hungary
Research Site, Nyiregyhaza, , Hungary
Research Site, Mexico City, Distrito F, Mexico
Research Site, Mexico City, Distrito F, Mexico
Research Site, Toluca, , Mexico
Research Site, Veracruz, , Mexico
Research Site, Bialystok, , Poland
Research Site, Bydgoszcz, , Poland
Research Site, Lublin, , Poland
Research Site, Lublin, , Poland
Research Site, Opole, , Poland
Research Site, Siedlce, , Poland
Research Site, Warszawa, , Poland
Research Site, Warszawa, , Poland
Research Site, Wroclaw, , Poland
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR